Effectiveness of Simeprevir Plus Sofosbuvir, With or Without Ribavirin, in Real-World Patients With HCV Genotype 1 Infection

Title
Effectiveness of Simeprevir Plus Sofosbuvir, With or Without Ribavirin, in Real-World Patients With HCV Genotype 1 Infection
Authors
Keywords
Chronic Hepatitis, Direct-Acting Agent, NS3/4A Protease Inhibitor, NS5B
Journal
GASTROENTEROLOGY
Volume 150, Issue 2, Pages 419-429
Publisher
Elsevier BV
Online
2015-10-25
DOI
10.1053/j.gastro.2015.10.013

Ask authors/readers for more resources

Reprint

Contact the author

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

Search

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now